90 related articles for article (PubMed ID: 18063140)
1. Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice.
Ruocco LA; Viggiano D; Pignatelli M; Iannaccone T; Rimoli MG; Melisi D; Curcio A; De Lucia S; Carboni E; Gironi Carnevale UA; de Caprariis P; Sadile AG
Behav Brain Res; 2008 Mar; 187(2):449-54. PubMed ID: 18063140
[TBL] [Abstract][Full Text] [Related]
2. Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD.
Ruocco LA; de Souza Silva MA; Topic B; Mattern C; Huston JP; Sadile AG
Eur Neuropsychopharmacol; 2009 Oct; 19(10):693-701. PubMed ID: 19328660
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats.
Ruocco LA; Viggiano D; Viggiano A; Abignente E; Rimoli MG; Melisi D; Curcio A; Nieddu M; Boatto G; Carboni E; Gironi Carnevale UA; Sadile AG
Neuroscience; 2008 Mar; 152(1):234-44. PubMed ID: 18164552
[TBL] [Abstract][Full Text] [Related]
4. Differential prepuberal handling modifies behaviour and excitatory amino acids in the forebrain of the Naples High-Excitability rats.
Ruocco LA; Gironi Carnevale UA; Sica A; Arra C; Topo E; Di Giovanni M; D'Aniello A; Sadile AG
Behav Brain Res; 2009 Mar; 198(1):29-36. PubMed ID: 18950660
[TBL] [Abstract][Full Text] [Related]
5. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
[TBL] [Abstract][Full Text] [Related]
6. Excitatory amino acids in the forebrain of the Naples high-excitability rats: neurochemical and behavioural effects of subchronic D-aspartate and its diethyl ester prodrug.
Ruocco LA; Di Pizzo A; Carnevale UA; Murolo M; Sadile AG; Arra C; Topo E; D'Aniello A; Curcio A; Melisi D; Rimoli MG
Behav Brain Res; 2009 Mar; 198(1):37-44. PubMed ID: 19041899
[TBL] [Abstract][Full Text] [Related]
7. Behavioural study of the D-galactose induced aging model in C57BL/6J mice.
Wei H; Li L; Song Q; Ai H; Chu J; Li W
Behav Brain Res; 2005 Feb; 157(2):245-51. PubMed ID: 15639175
[TBL] [Abstract][Full Text] [Related]
8. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
van der Kooij MA; Glennon JC
Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
[TBL] [Abstract][Full Text] [Related]
9. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
[TBL] [Abstract][Full Text] [Related]
10. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
Pliszka SR
Biol Psychiatry; 2005 Jun; 57(11):1385-90. PubMed ID: 15950012
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis?
Glaser PE; Surgener SP; Grondin R; Gash CR; Palmer M; Castellanos FX; Gerhardt GA
J Neurosci Methods; 2006 Feb; 151(1):62-7. PubMed ID: 16451810
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of object-based attention in mice.
Alkam T; Hiramatsu M; Mamiya T; Aoyama Y; Nitta A; Yamada K; Kim HC; Nabeshima T
Behav Brain Res; 2011 Jun; 220(1):185-93. PubMed ID: 21277334
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
Bymaster FP; Golembiowska K; Kowalska M; Choi YK; Tarazi FI
Synapse; 2012 Jun; 66(6):522-32. PubMed ID: 22298359
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
Oades RD
Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
[TBL] [Abstract][Full Text] [Related]
15. Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder (ADHD).
Pamplona FA; Pandolfo P; Savoldi R; Prediger RD; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1153-60. PubMed ID: 19549550
[TBL] [Abstract][Full Text] [Related]
16. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.
Oades RD; Sadile AG; Sagvolden T; Viggiano D; Zuddas A; Devoto P; Aase H; Johansen EB; Ruocco LA; Russell VA
Dev Sci; 2005 Mar; 8(2):122-31. PubMed ID: 15720370
[TBL] [Abstract][Full Text] [Related]
17. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
de Souza Silva MA; Topic B; Huston JP; Mattern C
Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
[TBL] [Abstract][Full Text] [Related]
18. ABT-724 alleviated hyperactivity and spatial learning impairment in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Yin P; Cao AH; Yu L; Guo LJ; Sun RP; Lei GF
Neurosci Lett; 2014 Sep; 580():142-6. PubMed ID: 25128216
[TBL] [Abstract][Full Text] [Related]
19. Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum.
Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Boatto G; Pagano C; Tino A; Nieddu M; Michel M; Prikulis I; Carboni E; de Souza Silva MA; Huston JP; Sadile AG; Korth C
Amino Acids; 2015 Mar; 47(3):637-50. PubMed ID: 25595600
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
